Syneron Medical Ltd (ELOS) Tops Q2 EPS by 2c, Revenues Exceed Expectations
Tweet
Share
E-mailGet Alerts ELOS Hot Sheet
Join SI Premium – FREE
Syneron Medical Ltd (NASDAQ: ELOS) reported Q2 EPS of $0.01, $0.02 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $60.6 million versus the consensus estimate of $54.04 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
- Beyond Air, Inc. (XAIR) Tops Q1 reported Q1 Revenue ; Offers Guidance
- Bending Spoons S.p.A. (BSP) Tops Q2 EPS by 19c; offers guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
